Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis

Lu, XQ; Hu, R; Peng, L; Liu, MS; Sun, Z

Sun, Z (corresponding author), Univ South China, Hengyang Med Coll, Hengyang, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2021; 12 ():

Abstract

Adalimumab, as a TNF inhibitor biologic for the treatment of rheumatoid arthritis, is one of the top-selling drugs worldwide. As its various patents h......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索